Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

2 Trials

Active Trials Phase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Glucose Intolerance

IT-DIAB, NCT01218061: Therapeutic Innovation in Type 2 DIABetes

Active, not recruiting

N/A

366

Europe

Pre-diabetes screening

Nantes University Hospital

Pre-diabetes

06/23

NCT02726256: G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance)

Not yet recruiting

N/A

500

RoW

Yonsei University

Type 2 Diabetes, Impaired Glucose Intolerance

02/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites